David W. Hutton - Concepedia

Author

David W. Hutton

University of Michigan ORCID

Also Known As

D Hutton, D. Hutton, D.W. Hutton, David Hutton, David W Hutton, David W. Hutton, David W. Hutton, MS

231

Publications

10.6K

Citations

H-Index

128

Concepts

All Affiliations

University of Michigan Stanford University Michigan Medicine Centers for Disease Control and Prevention Johns Hopkins University

About

David W. Hutton is an author at University of Michigan specializing in medicine, health economics, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	3	3	217
2	Arts	1	1	19
3	Education	1	1	35
4	Engineering	1	1	38
5	Law	1	1	29

David W. Hutton

Publications

3.8K

Citations

H-Index

Page 1

	Year	Citations
Cost-Effectiveness of Dabigatran Compared With Warfarin for Stroke Prevention in Atrial Fibrillation James V. Freeman, Ruo P. Zhu, Douglas K Owens, Annals of Internal Medicine	2011	427
Cost-effectiveness of Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema Treatment Eric L. Ross, David W. Hutton, Joshua D. Stein, JAMA Ophthalmology	2016	207
Cost-Effectiveness of Screening and Vaccinating Asian and Pacific Islander Adults for Hepatitis B David W. Hutton, Daniel S.W. Tan, Samuel So, Annals of Internal Medicine	2007	149
Cost-Effectiveness of Hepatocellular Carcinoma Surveillance: An Assessment of Benefits and Harms Neehar D. Parikh, Amit G. Singal, David W. Hutton, The American Journal of Gastroenterology	2020	140
Use of Respiratory Syncytial Virus Vaccines in Adults Aged ≥60 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2024 Amadea Britton, Lauren E. Roper, Camille N. Kotton, MMWR Morbidity and Mortality Weekly Report Respiratory Virus ImmunityRespiratory ComplicationsImmunologyAdvisory CommitteeVaccine Hesitancy	2024	127
Projected increase in obesity and non‐alcoholic‐steatohepatitis–related liver transplantation waitlist additions in the United States Neehar D. Parikh, Wesley J. Marrero, Jingyuan Wang, Hepatology	2017	122
Additional resource needs for viral hepatitis elimination through universal health coverage: projections in 67 low-income and middle-income countries, 2016–30 David Tordrup, Yvan Hutin, Karin Stenberg, The Lancet Global Health	2019	97
Cost-Effectiveness Analysis Evaluating Fidaxomicin versus Oral Vancomycin for the Treatment of Clostridium difficile Infection in the United States Paul M. Stranges, David W. Hutton, Curtis D. Collins Value in Health Antimicrobial SusceptibilityHealth SciencesAntibioticsHealth EconomicsHealthcare-associated Infection	2013	89
Cost-effectiveness analysis of alternative naloxone distribution strategies: First responder and lay distribution in the United States Tarlise Townsend, Freida Blostein, Tran T. Doan, International Journal of Drug Policy Opioid EpidemicSubstance AbuseCost-effectiveness AnalysisHealth EconomicsHealth Policy	2019	84
Cost-Effectiveness of Bevacizumab and Ranibizumab for Newly Diagnosed Neovascular Macular Degeneration Joshua D. Stein, Paula Anne Newman-Casey, Mrinalini Tavag, Ophthalmology Ocular DiseaseNeovascular Macular DegenerationOphthalmologyEye HealthGlaucoma	2014	83

Page 1